Skip to main content
Livermore
Livermore
ZHEN

Euclidean Capital LLC

SEC CIK
0001825034
Latest filing
Aug 14, 2026

Holdings in Q3 2021

Holdings as of Sep 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q2 2021.

Institution overview
Positions
10
−4 vs. Q2 2021
Portfolio value
$205.7M
−$102.4M (−33.2%) vs. Q2 2021
Filed
Nov 15, 2021
SEC
Holdings of Euclidean Capital LLC in Q3 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
PMVPPMV Pharmaceuticals, Inc.COM2,769,813$82.5M40.1%−1,138,864−29.1%ReducedHistory
ALECAlector, Inc.COM980,894$22.4M10.9%00.0%UnchangedHistory
RAPTRAPT Therapeutics, Inc.COM635,177$19.7M9.6%−100,624−13.7%ReducedHistory
TNYATenaya Therapeutics, Inc.COM915,705$18.9M9.2%+915,705NewHistory
FHTXFoghorn Therapeutics Inc.COM1,261,261$17.6M8.5%00.0%UnchangedHistory
NGMNGM Biopharmaceuticals IncCOM832,274$17.5M8.5%−661,075−44.3%ReducedHistory
ORICOric Pharmaceuticals, Inc.COM777,193$16.3M7.9%−219,541−22.0%ReducedHistory
SRZNSurrozen, Inc.COM802,965$5.68M2.8%+802,965NewHistory
FFBCFirst Financial BancorpCOM173,576$4.06M2.0%00.0%UnchangedHistory
PDDPDD Holdings Inc.SPONSORED ADS12,262$1.11M0.5%+2,456+25.0%AddedHistory

Sold out since Q2 2021 (6)

Positions held at the end of Q2 2021 that are gone from this filing.

Positions of Euclidean Capital LLC sold out since Q2 2021
SecurityClassShares in Q2 2021Value in Q2 2021% of portfolio in Q2 2021History
DNLIDenali Therapeutics Inc.COM323,749$25.4M8.2%History
CNSTConstellation Pharmaceuticals IncCOM554,325$18.7M6.1%History
SNOWSnowflake Inc.Stock47,136$11.4M3.7%History
NRIXNurix Therapeutics, Inc.COM154,426$4.10M1.3%History
BEAMBeam Therapeutics Inc.COM31,131$4.01M1.3%History
VIRVir Biotechnology, Inc.COM25,866$1.22M0.4%History